Kornelis Jan Storm is no longer serving in their board position at Baxter International, Inc.
May 15, 2018
Board and Executive Moves
Vice Chairman of the Board Directors & Chairman of the Board of Directors of the Audit Committee at Unilever PLC
In The News
May 15, 2018 - RelSci
Apr 08, 2018 - RelSci
Sep 16, 2015 - Associated Press Online
Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2011 sales of $13.9 billion and has approximately 48,500 employees.
In The News
The Anesthesia Gases market studied was valued at USD 1,588.07 million in 2018, and is expected to reach USD 1,969.18 million by 2024, with an anticipated CAGR of 3.65%, during the forecast period (2019
Nov 12, 2019 - PR Newswire
Nov 12, 2019 - Associated Press Financial Wire